Inventor · disambiguated record
Vickie Brown-Driver
Also filed as: BROWN-DRIVER VICKIE · BROWN-DRIVER VICKIE L
8 granted patents·23 pending applications·331 citations·filing 1993–2021
89Inventor score
Files withIONIS PHARMACEUTICALS INC12ISIS PHARMACEUTICALS INC7BROWN-DRIVER VICKIE L3TRIUS THERAPEUTICS INC3BENNETT C F2
Top patents by PatentIndex Score
31 records- 0195US8101743B2Modulation of transthyretin expressionBROWN-DRIVER VICKIE L·Filed 2008·Granted Jan 24, 2012·52 cites·9 claims
- 0292US5952490AOligonucleotides having a conserved G4 core sequenceISIS PHARMACEUTICALS INC·Filed 1993·Granted Sep 14, 1999·69 cites·27 claims
- 0390US5514577AOligonucleotide therapies for modulating the effects of herpes virusesISIS PHARMACEUTICALS INC·Filed 1993·Granted May 7, 1996·153 cites·2 claims
- 0483US6187587B1Antisense inhibition of e2f transcription factor 1 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Feb 13, 2001·19 cites·13 claims
- 0579US2022213474A1Modulation of transthyretin expressionLONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0675US2018179532A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0773US2018179529A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0873US2018179533A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0973US2018179535A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1073US2018179530A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1173US2018179528A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1273US2018179534A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1373US2018179537A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1473US2018179531A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1573US2018179536A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1672US8021665B2Identification and application of antibiotic synergyTRIUS THERAPEUTICS INC·Filed 2006·Granted Sep 20, 2011·2 cites·9 claims
- 1772US5698391AMethods for synthetic unrandomization of oligomer fragmentsISIS PHARMACEUTICALS INC·Filed 1994·Granted Dec 16, 1997·36 cites·80 claims
- 1872US2018273949A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1968US2016348100A1Modulation of transthyretin expressionIONIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2066US2015184157A1Modulation of transthyretin expressionISIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2164US2012149109A1Modulation of transthyretin expressionBROWN-DRIVER VICKIE L·Filed 2012·Application pending·0 cites
- 2259US2007015723A1Antiviral oligonucleotides having a conserved G4 core sequenceISIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2357US2005026857A1Antisense modulation of breast cancer-1 expressionFiled 2003·Application pending·0 cites
- 2455US2005261228A1Antisense modulation of interleukin 12 P35 subunit expressionBENNETT C F·Filed 2005·Application pending·0 cites
- 2554US2004014051A1Antisense modulation of breast cancer-1 expressionISIS PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 2653US2011124715A1Antiviral Oligonucleotides Having a Conserved G4 Core SequenceHANECAK RONNIE C·Filed 2010·Application pending·0 cites
- 2747US2005244869A1Modulation of transthyretin expressionBROWN-DRIVER VICKIE L·Filed 2005·Application pending·0 cites
- 2846US7910337B2Method for identifying drug-sensitizing antisense DNA fragments and use thereofTRIUS THERAPEUTICS INC·Filed 2006·Granted Mar 22, 2011·0 cites·48 claims
- 2944US2011143359A1Method for Identifying Drug-Sensitizing Antisense DNA Fragments and Use ThereofTRIUS THERAPEUTICS INC·Filed 2011·Application pending·0 cites
- 3043US8298543B2Identification and application of antibiotic synergyBROWN-DRIVER VICKIE·Filed 2011·Granted Oct 30, 2012·0 cites·10 claims
- 3141US2006154885A1Modulation of SLC26A2 expressionBENNETT C F·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →